Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Northrop Grumman
NOC
|
+$305M |
| 2 |
Prologis
PLD
|
+$97.9M |
| 3 |
Carlisle Companies
CSL
|
+$29.2M |
| 4 |
Healthcare Realty
HR
|
+$28.7M |
| 5 |
Gaming and Leisure Properties
GLPI
|
+$27.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$102M |
| 2 |
DRE
Duke Realty Corp.
DRE
|
+$91.2M |
| 3 |
Chevron
CVX
|
+$54.7M |
| 4 |
CTXS
Citrix Systems Inc
CTXS
|
+$52.9M |
| 5 |
Microsoft
MSFT
|
+$27.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.12% |
| 2 | Healthcare | 15.83% |
| 3 | Consumer Discretionary | 12.65% |
| 4 | Industrials | 8.88% |
| 5 | Communication Services | 8.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1376
Trustmark
TRMK
$2.8B
| $4.24M | ﹤0.01% |
138,500
+800
| +0.6% | +$25.4K |
|
1377
Genworth Financial
GNW
$3.77B
| $4.24M | ﹤0.01% |
1,210,586
+10,800
| +0.9% | +$43.6K |
|
|
CSW
1378
CSW Industrials
CSW
$5.59B
| $4.24M | ﹤0.01% |
35,349
-200
| -0.6% | -$24.5K |
|
|
FBC
1379
DELISTED
Flagstar Bancorp, Inc. New
FBC
| $4.22M | ﹤0.01% |
126,300
+1,300
| +1% | +$49.7K |
|
1380
Sonos
SONO
$1.96B
| $4.22M | ﹤0.01% |
303,300
+2,700
| +0.9% | +$47.9K |
|
1381
ArcBest
ARCB
$3.28B
| $4.21M | ﹤0.01% |
57,900
| – | – |
|
1382
ScottsMiracle-Gro
SMG
$3.59B
| $4.21M | ﹤0.01% |
98,500
+300
| +0.3% | +$21.5K |
|
1383
Cavco Industries
CVCO
$4.67B
| $4.2M | ﹤0.01% |
20,400
-100
| -0.5% | -$23.7K |
|
|
MDRX
1384
DELISTED
Veradigm Inc. Common Stock
MDRX
| $4.19M | ﹤0.01% |
275,100
+1,400
| +0.5% | +$22.6K |
|
1385
Viper Energy
VNOM
$14.8B
| $4.18M | ﹤0.01% |
146,000
+900
| +0.6% | +$26.2K |
|
1386
CareTrust REIT
CTRE
$9.18B
| $4.16M | ﹤0.01% |
229,449
| – | – |
|
1387
Renasant Corp
RNST
$4B
| $4.15M | ﹤0.01% |
132,600
+800
| +0.6% | +$26K |
|
1388
Relay Therapeutics
RLAY
$4.37B
| $4.14M | ﹤0.01% |
184,900
+31,900
| +21% | +$700K |
|
|
ACH
1389
Accendra Health
ACH
$84.6M
| $4.13M | ﹤0.01% |
171,500
+2,000
| +1% | +$61.6K |
|
1390
Boot Barn
BOOT
$4.92B
| $4.12M | ﹤0.01% |
70,500
+400
| +0.6% | +$26.8K |
|
1391
Fate Therapeutics
FATE
$294M
| $4.11M | ﹤0.01% |
183,300
+1,600
| +0.9% | +$46.2K |
|
1392
LGI Homes
LGIH
$1.37B
| $4.11M | ﹤0.01% |
50,481
-200
| -0.4% | -$19.6K |
|
1393
Delek US
DK
$4.18B
| $4.1M | ﹤0.01% |
150,991
-6,700
| -4% | -$177K |
|
1394
Impinj
PI
$5.46B
| $4.1M | ﹤0.01% |
51,200
+1,700
| +3% | +$142K |
|
|
CPE
1395
DELISTED
Callon Petroleum Company
CPE
| $4.1M | ﹤0.01% |
117,000
+1,000
| +0.9% | +$39.9K |
|
|
EDR
1396
DELISTED
Endeavor Group Holdings, Inc.
EDR
| $4.09M | ﹤0.01% |
202,000
+12,200
| +6% | +$276K |
|
1397
AtriCure
ATRC
$2.21B
| $4.08M | ﹤0.01% |
104,300
+1,200
| +1% | +$54.9K |
|
|
CSGS
1398
DELISTED
CSG Systems International
CSGS
| $4.07M | ﹤0.01% |
76,900
+700
| +0.9% | +$40.8K |
|
1399
Extreme Networks
EXTR
$3.16B
| $4.06M | ﹤0.01% |
310,300
+6,000
| +2% | +$75.7K |
|
|
ROIC
1400
DELISTED
Retail Opportunity Investments Corp.
ROIC
| $4.05M | ﹤0.01% |
294,500
+5,300
| +2% | +$87.5K |
|
Similar funds
Swiss National Bank's Q3 2022 Portfolio in Review
As of Q3 2022, Swiss National Bank held 2,744 positions worth $140B, down 5.4% from $148B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Trading was light in Q3 2022: portfolio turnover was 1.2%. Swiss National Bank opened 4 new positions and exited 30, leaving the 2,744-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Swiss National Bank's largest Q3 2022 buy was Northrop Grumman: 639,945 shares worth $301M.
- Swiss National Bank added most to Prologis in Q3 2022, an estimated $97.9M increase.
- Swiss National Bank's biggest Q3 2022 reduction was Apple, cutting an estimated $102M.
- Swiss National Bank fully exited Duke Realty Corp. in Q3 2022, selling an estimated $91.2M.
- Swiss National Bank's ten largest holdings make up 26% of its $140B portfolio in Q3 2022.
- Swiss National Bank opened 4 new positions and closed 30 in Q3 2022.
- Swiss National Bank's portfolio value fell 5.4% quarter-over-quarter to $140B.
Based on Swiss National Bank's 13F filing for Q3 2022, filed 9 Nov 2022.